Determines a woman’s risk of having ovarian cancer.
The ROCA Test is intended for women who are between 50 and 85 years old and have been through menopause, or between 35 and 85 years old with a family history of ovarian and/or breast cancer, are of Ashkenazi Jewish descent with a known family history of ovarian or breast cancer, or have tested positive for BRCA1, BRCA2 or Lynch syndrome gene mutation.
Researchers from the UKCTOCS and UK FOCSS trials provide a response to clarify results after the U.S. FDA releases a statement on ovarian cancer screening.Read more
Abcodia has released a response to the FDA's statement on ovarian cancer screening released on 7 Sept 2016. Notwithstanding our confidence in the clinical utility of the ROCA Test, we have voluntarily decided to temporarily limit the availability of the ROCA Test in the United Kingdom.Read more